(Q53591741)

16 May 2018

title

Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year. (English)

1 reference

16 May 2018

author name string

L D Cornell

1

1 reference

16 May 2018

C A Schinstock

2

1 reference

16 May 2018

M J Gandhi

3

1 reference

16 May 2018

W K Kremers

4

1 reference

16 May 2018

M D Stegall

5

1 reference

16 May 2018

language of work or name

English

0 references

publication date

2 March 2015

1 reference

16 May 2018

American Journal of Transplantation

published in

1 reference

16 May 2018

volume

15

1 reference

16 May 2018

issue

5

1 reference

16 May 2018

page(s)

1293-1302

1 reference

16 May 2018

Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches

cites work

1 reference

Assessing the efficacy of kidney paired donation--performance of an integrated three-site program

21 January 2018

1 reference

Desensitization in HLA-incompatible kidney recipients and survival.

21 January 2018

1 reference

Five-year outcomes in living donor kidney transplants with a positive crossmatch.

21 January 2018

1 reference

Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation

21 January 2018

1 reference

Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.

21 January 2018

1 reference

Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation

21 January 2018

1 reference

Banff 07 classification of renal allograft pathology: updates and future directions

21 January 2018

1 reference

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions

21 January 2018

1 reference

The spectrum of antibody-mediated renal allograft injury: implications for treatment

21 January 2018

1 reference

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

21 January 2018

1 reference

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

21 January 2018

1 reference

Long-term experience of plasmapheresis in antibody-mediated rejection in renal transplantation

21 January 2018

1 reference

Proteasome inhibition for antibody-mediated rejection

21 January 2018

1 reference

Complement and its role in innate and adaptive immune responses

21 January 2018

1 reference

The role of the anaphylatoxins in health and disease

21 January 2018

1 reference

Complement-binding anti-HLA antibodies and kidney-allograft survival

21 January 2018

1 reference

NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.

21 January 2018

1 reference

Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation

21 January 2018

1 reference

Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection

21 January 2018

1 reference

Role of complement and NK cells in antibody mediated rejection

21 January 2018

1 reference

A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody

21 January 2018

1 reference

Kidney allograft survival after acute rejection, the value of follow-up biopsies

21 January 2018

1 reference

An integrated view of molecular changes, histopathology and outcomes in kidney transplants

21 January 2018

1 reference

Incidence and impact of de novo donor-specific alloantibody in primary renal allografts

21 January 2018

1 reference

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AJT.13168

1 reference

16 May 2018

1 reference

16 May 2018